The clinical impact of edoxaban for the patients with postoperative anemia after total hip arthroplasty

Author:

Izushi Yasuhisa,Shiota Naofumi,Tetsunaga Tomonori,Shimada Kenichi,Egawa Takashi,Kiuchi Tsukasa,Sato Toru,Takuma Ritsugi,Takami Yoichiro

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Surgery

Reference25 articles.

1. Steuber TD, Howard ML, Nisly SA (2016) Strategies for the management of postoperative anemia in elective orthopedic surgery. Ann Pharmacother 50:578–585

2. Spahn DR (2010) Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 113:482–495

3. Liu X, Zhang X, Chen Y, Wang Q, Jiang Y, Zeng B (2011) Hidden blood loss after total hip arthroplasty. J Arthroplasty 26(1100–1105):e1

4. Kawaji H, Ishii M, Tamaki Y, Sasaki K, Takagi M (2012) Edoxaban for prevention of venous thromboembolism after major orthopedic surgery. Orthop Res Rev 4:53–64

5. Daiichi Sankyo Limited. Daiichi Sankyo launches LIXIANA®tablets (edoxaban), a direct oral factor Xa inhibitor, in Japan for the prevention of venous thromboembolism after major orthopedic surgery: first direct oral factor Xa inhibitor available to Japanese patients. http://www.daiichisankyo.co.jp/news/detail/005457.html . Accessed 10 Jan 2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3